Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: placebo Sponsor : Hoffmann-La Roche Active, not recruiting - verified July 2011

This Is A Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis

Condition : Juvenile Idiopathic Arthritis Interventions : Biological: adalimumab; Drug: Methotrexate Sponsors : AbbVie; AbbVie (prior sponsor, Abbott) Recruiting - verified July 2013

Condition : Knee Osteoarthritis Intervention : Sponsors : University of Pittsburgh; National Institutes of Health (NIH) Active, not recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: Placebo Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: BIIB023; Other: Placebo (sterile normal saline) Sponsors : Biogen Idec; Biogen Idec Completed - verified May 2011

The purpose of the study is to assess early signs of response to Abatacept+MTX my measuring improvement of your hand joints inflammation by using an ultrasound machine.

The purpose of the study is to assess early signs of response to Abatacept+MTX my measuring improvement of your hand joints inflammation by using an ultrasound machine.

Condition : Rheumatoid Arthritis Intervention : Drug: Etanercept Sponsors : Wyeth is now a wholly owned subsidiary of Pfizer; Lincoln; Umanis; SODIA; depolabo Completed - verified July 2011

Condition : Rheumatoid Arthritis Intervention : Drug: Etanercept Sponsors : Wyeth is now a wholly owned subsidiary of Pfizer; Lincoln; Umanis; SODIA; depolabo Completed - verified July 2011